A systematic review of hydromorphone in acute and chronic pain.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pain and Symptom Management

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0885-3924(02)00643-7PMID 12590032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of hydromorphone and meperidine for ureteral colic.

  2008cited by this paper
• Hydromorphone for acute and chronic pain.

  2002cited by this paper
• Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing.

  2001cited by this paper
• Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery

  1999cited by this paper
• A RANDOMISED CROSSOVER COMPARISON OF CONTROLLED RELEASE HYDROMORPHONE TABLETS WITH CONTROLLED RELEASE MORPHINE TABLETS IN PATIENTS WITH CANCER PAIN

  1999cited by this paper
• A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia.

  1998cited by this paper
• Size is everything – large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

  1998cited by this paper
• Comparative clinical efficacy and safety of a novel controlled‐release oxycodone formulation and controlled‐release hydromorphone in the treatment of cancer pain

  1997cited by this paper
• Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales

  1997cited by this paper
• Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study

  1997cited by this paper
• A comparison of analgesic efficacy, patient satisfaction, and cost of three spinal-epidural analgesic regimens in the laboring parturient

  1997cited by this paper
• Patient-Controlled Epidural Analgesia: Interactions Between Nalbuphine and Hydromorphone

  1997cited by this paper
• Comparative efficacy of patient‐controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation

  1997cited by this paper
• Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.

  1996cited by this paper
• Epidural morphine vs hydromorphone in post-Caesarean section patients

  1996cited by this paper
• A Multidimensional Comparison of Morphine and Hydromorphone Patient-Controlled Analgesia

  1996cited by this paper
• A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group.

  1996cited by this paper
• Hydromorphone and metabolite pharmacokinetics in children.

  1995cited by this paper
• Opioid pharmacotherapy in the management of cancer pain. A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration

  1995cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Intravenous Versus Epidural Administration of Hydromorphone: Effects on Analgesia and Recovery after Radical Retropubic Prostatectomy

  1995cited by this paper
• Pain outcomes after thoracotomy: lumbar epidural hydromorphone versus intrapleural bupivacaine.

  1995cited by this paper
• Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery

  1994cited by this paper
• Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain

  1994cited by this paper
• New clinical-practice guidelines for the management of pain in patients with cancer.

  1994cited by this paper
• Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study

  1993cited by this paper
• Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison.

  1992cited by this paper
• Epidural patient-controlled analgesia: an alternative to intravenous patient-controlled analgesia for pain relief after cesarean delivery.

  1992cited by this paper
• Epidural patient-controlled analgesia: influence of bupivacaine and hydromorphone basal infusion on pain control after cesarean delivery.

  1992cited by this paper
• Spinal narcotics for postoperative analgesia in total joint arthroplasty. A prospective study.

  1991cited by this paper
• Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain.

  1991cited by this paper
• Clinical analgesic assay of repeated and single doses of heroin and hydromorphone

  1990cited by this paper
• Epidural Hydromorphone With and Without Epinephrine for Post‐Operative Analgesia After Cesarean Delivery

  1989cited by this paper
• Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain.

  1988cited by this paper
• Patient-controlled analgesia: a comparison of intravenous versus subcutaneous hydromorphone.

  1988cited by this paper
• Epidural hydromorphone: a double-blind comparison with intramuscular hydromorphone for postcesarean section analgesia.

  1987cited by this paper
• Continuous subcutaneous infusion of morphine.

  1986cited by this paper
• EFFECTS OF EPINEPHRINE ON EPIDURAL FENTANYL, SUFENTANIL AND HYDROMORPHONE FOR POSTOPERATIVE ANALGESIA

  1985cited by this paper
• Epidural Hydromorphone for Postcesarean Analgesia

  1985cited by this paper
• Comparison of indomethacin and dihydromorphinone in acute, biliary stone pain

  1984cited by this paper
• Relative analgesic potencies of morphine and hydromorphone in postoperative pain.

  1975cited by this paper
• Dental evaluation of hydromorphone (Dilaudid) for oral and maxillo-facial surgery.

  1969cited by this paper
• Dental evaluation of hydromorphone (Dilaudid) for oral and maxillo-facial surgery.

  1969cited by this paper
• Postoperative Analgesia with Hydromorphone and Meperidine: A Double‐Blind Comparison

  1968cited by this paper
• ORAL HYDROMORPHONE IN TRAUMA.

  1965cited by this paper
• ORAL HYDROMORPHONE IN TRAUMA.

  1965cited by this paper
• AN Evaluation OF DIHYDROMORPHINONE* IN TREATING POSTOPERATIVE PAIN

  1962cited by this paper

• Thermal antinociceptive effects after intramuscular administration of high doses of hydromorphone in cockatiels (Nymphicus hollandicus).

  2025cites this paper
• Patient-controlled subcutaneous analgesia with hydromorphone in cancer pain management

  2025cites this paper
• Opioidergic pain relief in humans is mediated by beta and high-gamma modulation in limbic regions

  2025cites this paper
• Analgesic efficacy of hydromorphone in American alligators (Alligator mississippiensis)

  2025cites this paper
• Chronic pain is a risk factor for all-cause and cancer-specific mortality in cancer survivors: a population-based cohort study

  2025cites this paper
• Cancer Pain Is Not One-Size-Fits-All: Evolving from Tradition to Precision

  2025cites this paper
• Unveiling the link between chronic pain and misuse of opioids and cannabis

  2024cites this paper
• Efficacy and safety of hydromorphone for cancer pain: a systematic review and meta-analysis

  2024cites this paper
• Opioids today: From pharmacology to crisis management and emerging solutions

  2024cites this paper
• Efficacy of patient-controlled hydromorphone analgesia in those undergoing uterine fibroid artery embolization via the right radial artery

  2023cites this paper
• High bioavailability, short half-life, and metabolism into hydromorphone-3-glucuronide following single intramuscular and intravenous administration of hydromorphone hydrochloride to great horned owls (Bubo virginianus).

  2023cites this paper
• Safety and efficacy of intravenous hydromorphone patient-controlled analgesia versus intramuscular pethidine in acute pancreatitis: An open-label, randomized controlled trial

  2022cites this paper
• Anesthetic Drugs: A Comprehensive Overview for Primary Care

  2022cites this paper
• Anesthetic drugs: a comprehensive overview for anesthesiologists

  2021cites this paper
• Hydromorphone for cancer pain.

  2021cites this paper
• Evaluation of the thermal antinociceptive effects of hydromorphone hydrochloride after intramuscular administration to orange-winged Amazon parrots (Amazona amazonica).

  2020cites this paper
• Pharmacokinetics of hydromorphone hydrochloride after intramuscular and intravenous administration of a single dose to orange-winged Amazon parrots (Amazona amazonica).

  2020cites this paper
• Perioperative Pain Management

  2020cites this paper
• Intravenous hydromorphone after thoracoscopic lobectomy: a double‐blind up‐and‐down sequential allocation trial of effective doses

  2019cites this paper
• ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2018; 2(4): e45

  2019cites this paper
• Sedation, Sleep, Delirium, and Rehabilitation

  2019cites this paper
• Intravenous hydromorphone after thoracoscopic lobectomy: a double-blind up-and-down sequential allocation trial of effective doses

  2019cites this paper
• Pharmacokinetics and Pharmacology of Drugs Used in Children

  2019cites this paper
• Pooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain.

  2019cites this paper
• Side effect profiles of different opioids in the perioperative setting: are they different and can we reduce them?

  2019cites this paper
• Pharmacological interventions for chronic pain in children: an overview of systematic reviews.

  2019cites this paper
• Acute and chronic pain in nonverbal children with neurological disorders. Possibilities of diagnosis and treatment. Systematic review

  2019cites this paper
• Evaluation of the thermal antinociceptive effects and pharmacokinetics of hydromorphone hydrochloride after intramuscular administration to cockatiels (Nymphicus hollandicus).

  2018cites this paper
• The Effect of Epidural Morphine-Bupivacaine Combined with a Low Dose of Naloxone on Respiratory Function and Analgesia in Patients with Chronic Low-Back Pain

  2018cites this paper
• L’hydromorphone dans le cadre du changement d’opioïde en oncologie

  2018cites this paper
• Sustained Release Opioids or Continuous Infusions + PCA Is Safe in the Opioid-Naïve Post-Operative Patient

  2017cites this paper
• A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)

  2017cites this paper
• Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis

  2016cites this paper
• Opioid Receptor Agonists and Antagonists

  2016cites this paper
• Pharmacology and antinociception of a sustained-released butorphanol – poloxamer 407 formulation in Amazon parrots

  2016cites this paper
• The effect of hydromorphone for postoperative analgesia in children

  2016cites this paper
• Hydromorphone for cancer pain.

  2016cites this paper
• Patient-controlled analgesia in the pediatric population: morphine versus hydromorphone

  2014cites this paper
• Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).

  2014cites this paper
• Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).

  2014cites this paper
• PAIN MANAGEMENT IN PALLIATIVE CANCER PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF HIGH DOSAGES OF TRANSDERMAL BUPRENORPHINE

  2013cites this paper
• Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain

  2013cites this paper
• Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing

  2013cites this paper
• Pediatric Critical Care Perceptions on Analgesia, Sedation, and Delirium

  2013cites this paper
• Results of a Double‐blind, Placebo‐controlled, Fixed‐dose Assessment of Once‐daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarthritis

  2013cites this paper
• Sustained Safety and Efficacy of Once‐Daily Hydromorphone Extended‐Release (OROS® hydromorphone ER) Compared with Twice‐Daily Oxycodone Controlled‐Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain

  2013cites this paper
• Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies.

  2012cites this paper
• Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS® hydromorphone ER) in patients with chronic pain

  2012cites this paper
• Effect of ketamine on intravenous patient-controlled analgesia using hydromorphone and ketorolac after the Nuss surgery in pediatric patients

  2012cites this paper
• Pain Management in Post-Craniotomy Patients: A Survey of Canadian Neurosurgeons

  2011cites this paper
• Higher doses of opioids in patients who need palliative sedation prior to death: cause or consequence?

  2011cites this paper
• Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids

  2011cites this paper
• Pharmacology of Chronic Pain Management the brain may alter the cerebrospinal fluid – brain and blood – brain concentration ratios and drug partitioning independent of the permeability of the blood – brain barrier

  2011cites this paper
• Pharmacotherapy for acute pain in children: current practice and recent advances

  2011cites this paper
• Pharmacology of Chronic Pain Management

  2011cites this paper
• A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury.

  2010cites this paper
• REVIEW ARTICLE The Role of OROS ® Hydromorphone in the Management of Cancer Pain

  2010cites this paper
• Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain

  2010cites this paper
• The Role of OROS® Hydromorphone in the Management of Cancer Pain

  2010influential citation
• Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain.

  2010cites this paper
• A Randomized Study to Demonstrate Noninferiority of Once‐Daily OROS® Hydromorphone with Twice‐Daily Sustained‐Release Oxycodone for Moderate to Severe Chronic Noncancer Pain

  2010cites this paper
• Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.

  2010cites this paper
• Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis.

  2010cites this paper
• Palliative Care Pain Management

  2009cites this paper
• Advances in the management of pain in children: acute pain.

  2009cites this paper
• Transdermal Iontophoresis of Hydromorphone across Hairless Rat Skin In Vitro

  2009cites this paper
• Pain in Children

  2009cites this paper
• An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

  2009cites this paper
• Pharmacologic management of acute pediatric pain.

  2009cites this paper
• Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain

  2008cites this paper
• Topical Anesthesia for Pressure Ulcer Treatment

  2008cites this paper
• A new extended release formulation (OROS®) of hydromorphone in the management of pain

  2008cites this paper
• Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol

  2008influential citation
• Analgesic Medications for Acute Pain Management in Children

  2008cites this paper
• Antalgiques et soins palliatifs

  2008cites this paper
• Recommendations for end-of-life care in the intensive care unit: A consensus statement by the American College of Critical Care Medicine

  2008cites this paper
• Advances in Pediatric Pain Management

  2007cites this paper
• Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO‑127)

  2007cites this paper
• Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats.

  2007cites this paper
• Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms.

  2007cites this paper
• The Pharmacologic Management of Cancer Pain

  2007cites this paper
• Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone

  2007cites this paper
• Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.

  2007cites this paper
• Opioid Analgesic Drugs

  2006cites this paper
• Clinical spectrum of the osmotic-controlled release oral delivery system (OROS*), an advanced oral delivery form

  2006cites this paper
• Managing Cancer Pain and Symptoms of Outpatients by Rotation to Sustained-release Hydromorphone: A Prospective Clinical Trial

  2006cites this paper
• Capillary electrophoresis contributions to the hydromorphone metabolism in man

  2006cites this paper
• Intravenous nalbuphine 50 µg·kg-1 is ineffective for opioid-induced pruritus in pediatrics

  2006cites this paper
• Intravenous nalbuphine 50 microg x kg(-1) is ineffective for opioid-induced pruritus in pediatrics.

  2006cites this paper
• A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain.

  2006cites this paper
• 5.1 Mésothéliome pleural malin Douleur physique et morale

  2006cites this paper
• [Pain management in gastrointestinal oncology].

  2005cites this paper
• The Efficacy and Incidence of Side Effects in Patient Controlled Analgesia Using Hydromorphone

  2005cites this paper
• Opioids and the management of cancer pain

  2005cites this paper
• Stark wirksame Opioidanalgetika und Obstipation

  2005cites this paper
• The role of opioids in cancer pain

  2005cites this paper
• Children’s Health: Sour News for Soy Formula?

  2005cites this paper
• Pediatric acute pain management.

  2005cites this paper
• Opioid analgesics for cancer pain in primary care

  2005cites this paper
• [Strong opioids and constipation].

  2005cites this paper